Aβ1-42 oligomers induced a short-term increase of glutamate release prior to its depletion as measured by amperometry on single varicosities.

Xiaoke Yang,Yun Tang,Quan-Fa Qiu,Wen-Tao Wu,Fu-Li Zhang,Yan-Ling Liu,Wei-Hua Huang

DOI: https://doi.org/10.1021/acs.analchem.9b03826

IF: 7.4

2019-01-01

Analytical Chemistry

Abstract:Glutamate (Glu) is a critical neurotransmitter for neuronal communication in the nervous system. In vivo studies have shown that the concentration of Glu is reduced within the brains of those afflicted with Alzheimer's disease (AD), which is also associated with the accumulation of pathogenic amyloid-beta (A beta). However, the effects of A beta peptides on the level of Glu release, as well as how A beta-mediated Glu fluctuation is initiated, remain largely unknown. Here, we fabricated a Glu electrochemical biosensor and in situ quantitatively monitored the release of Glu from a single varicosity of A beta(1-42)-insulted hippocampal neurons. We found that before the depletion of Glu after 300 min of treatment with A beta(1-42), a short-duration (30 min) incubation with A beta(1-42) caused a dramatic increase in vesicular Glu release compared to that of a control. Further investigation demonstrated that the density of vesicular glutamate transporter 1 (VGLUT1), which is responsible for transport of Glu into synaptic vesicles, also displayed a significant elevation and then dramatic depletion with the extension of the time of treatment with A beta(1-42). These results indicate that at the early stage of AD, A beta(1-42) induces excessive Glu release, which may overstimulate the N-methyl-n-aspartic acid (NMDA) receptor, resulting in excitotoxicity and damage to neurons. In this work, the amount of Glu released together with its fluctuations under A beta(1-42) oligomers toxicity conditions was monitored for the first time, and such monitoring could provide direct and new insights for current research on A beta(1-42)-induced abnormalities in neurotransmitter release and neuron functions.